S
Stéphane Terry
Researcher at Université Paris-Saclay
Publications - 69
Citations - 4375
Stéphane Terry is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 27, co-authored 64 publications receiving 3580 citations. Previous affiliations of Stéphane Terry include Curie Institute & French Institute of Health and Medical Research.
Papers
More filters
Journal ArticleDOI
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
Himisha Beltran,David S. Rickman,Kyung Park,Sung Suk Chae,Andrea Sboner,Theresa Y. MacDonald,Yuwei Wang,Karen Sheikh,Stéphane Terry,Scott T. Tagawa,Rajiv Dhir,Joel B. Nelson,Alexandre de la Taille,Yves Allory,Mark Gerstein,Sven Perner,Kenneth J. Pienta,Arul M. Chinnaiyan,Arul M. Chinnaiyan,Yuzhuo Wang,Colin Collins,Martin E. Gleave,Francesca Demichelis,Francesca Demichelis,David M. Nanus,Mark A. Rubin +25 more
TL;DR: There was dramatic and enhanced sensitivity of NEPC (and MYCN overexpressing PCA) to Aurora kinase inhibitor therapy both in vitro and in vivo, with complete suppression of neuroendocrine marker expression following treatment.
Journal ArticleDOI
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Muhammad Zaeem Noman,Meriem Hasmim,Yosra Messai,Stéphane Terry,Claudine Kieda,Bassam Janji,Salem Chouaib +6 more
TL;DR: The potential role of hypoxia, a major feature of most solid tumors, within the tumor microenvironment and how it contributes to immune resistance and immune suppression/tolerance and can be detrimental to antitumor effector cell functions is outlined.
Journal ArticleDOI
New insights into the role of EMT in tumor immune escape
Stéphane Terry,Pierre Savagner,Sandra Ortiz-Cuaran,Linda Mahjoubi,Pierre Saintigny,Jean Paul Thiery,Jean Paul Thiery,Jean Paul Thiery,Salem Chouaib +8 more
TL;DR: Current knowledge of how cellular heterogeneity and plasticity could be involved in shaping the tumor microenvironment (TME) and in controlling antitumor immunity is reviewed.
Journal ArticleDOI
Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis
Grégoire Robert,Aurélien Descazeaud,Nathalie Nicolaiew,Stéphane Terry,Nanor Sirab,Francis Vacherot,Pascale Maillé,Yves Allory,Alexandre de la Taille +8 more
TL;DR: The aim was to characterize inflammatory cells infiltrate within BPH tissue and to correlate inflammation and clinical data.
Journal ArticleDOI
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
Dorothee Pflueger,Stéphane Terry,Andrea Sboner,Lukas Habegger,Raquel Esgueva,Pei-Chun Lin,Maria A. Svensson,Naoki Kitabayashi,Benjamin J. Moss,Theresa Y. MacDonald,Xuhong Cao,Terrence R. Barrette,Ashutosh Tewari,Mark S. Chee,Arul M. Chinnaiyan,David S. Rickman,Francesca Demichelis,Mark Gerstein,Mark A. Rubin +18 more
TL;DR: Seven new cancer-specific gene fusions are discovered and characterized, two involving the ETS genes ETV1 and ERG, and four involving non-ETS genes such as CDKN1A, CD9, and IKBKB, genes known to exhibit key biological roles in cellular homeostasis or assumed to be critical in tumorigenesis of other tumor entities.